Soleus Capital Management, L.P. Arvinas, Inc. Transaction History
Soleus Capital Management, L.P.
- $1.18 Billion
- Q3 2024
A detailed history of Soleus Capital Management, L.P. transactions in Arvinas, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 228,800 shares of ARVN stock, worth $4.03 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
228,800Holding current value
$4.03 Million% of portfolio
0.48%Shares
7 transactions
Others Institutions Holding ARVN
# of Institutions
227Shares Held
68.4MCall Options Held
226KPut Options Held
285K-
Vanguard Group Inc Valley Forge, PA7.01MShares$123 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$118 Million7.19% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$110 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$67.9 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.78MShares$49 Million1.09% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $937M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...